#1998年リリースの中から最高の4枚を選ぶ# ・『XO』Elliott Smith ・『Music Has the Right to Children』 　　　　　　　　　　　　Boards of Canada ・『Mezzanine』Massive Attack ・『In the Aeroplane Over the Sea』 　　　　　　　　　　　　Neutral Milk Hotel

Countries by Crude Steel Production (in Million Metric Tons) 1. 🇨🇳 China - 960.8 2. 🇮🇳 India - 164.9 3. 🇺🇸 United States - 82.0 4. 🇯🇵 Japan - 80.7 5. 🇷🇺 Russia - 67.8 6. 🇰🇷 South Korea - 61.9 7. 🇹🇷 Turkey - 38.1 8. 🇩🇪 Germany - 34.1 9. 🇧🇷 Brazil - 33.3 10. 🇮🇷 Iran - 31.8 11. 🇻🇳 Vietnam - 24.7 12. 🇮🇹 Italy - 20.7 13. 🇮🇩 Indonesia - 19.0 14. 🇹🇼 Taiwan - 17.1 15. 🇲🇽 Mexico - 13.5 16. 🇪🇸 Spain - 11.9 17. 🇨🇦 Canada - 11.5 18. 🇸🇦 Saudi Arabia - 10.8 19. 🇪🇬 Egypt - 10.6 20. 🇫🇷 France - 9.8 Source: World Steel Association (2025/2026 Data)

Childhood poverty rates 🇺🇸 21.1% 🇬🇧 15.8% 🇮🇹 14.5% 🇨🇦 14.0% 🇱🇺 13.5% 🇵🇹 12.5% 🇬🇷 12.3% 🇫🇷 12.0% 🇦🇹 9.8% 🇩🇪 9.1% 🇨🇭 9.1% 🇨🇿 8.8% 🇰🇷 8.5% 🇸🇪 8.4% 🇳🇱 8.4% 🇧🇪 7.9% 🇳🇴 6.9% 🇮🇪 6.8% 🇫🇮 4.6% We must end the outrage that in the richest country in the history of the world, more than 1 in 5 children live in poverty.

[Rerun Pick-Up Recruitment Preview] A Rerun Pick-Up Recruitment will begin on 9/1 (Tue)! 💌Pick-Up Students: 3★ Akari (New Year), 3★ Izumi (New Year), 3★ Haruka (New Year) 🗓️Pick-Up Recruitment Schedule: 9/1 (Tue) 2:00 AM – 9/8 (Tue) 1:59 AM (UTC) #BlueArchive#

[Rerun Pick-Up Recruitment Preview] A Rerun Pick-Up Recruitment will begin on 9/1 (Tue)! 💌Pick-Up Students: 3★ Sumire (Part-Timer), 3★ Rei 🗓️Pick-Up Recruitment Schedule: 9/1 (Tue) 2:00 AM – 9/8 (Tue) 1:59 AM (UTC) #BlueArchive#

Child Poverty Rate in OECD Share of population aged 0-17 living in poverty: 1. 🇨🇷 Costa Rica: 29.6% 2. 🇮🇱 Israel: 23.2% 3. 🇪🇸 Spain: 21.5% 4. 🇺🇸 United States: 21.1% 5. 🇧🇬 Bulgaria: 19.1% 6. 🇷🇴 Romania: 17.7% 7. 🇬🇧 UK: 15.8% 8. 🇮🇹 Italy: 14.5% 9. 🇨🇦 Canada: 14.0% 10. 🇱🇺 Luxembourg: 13.5% 11. 🇱🇹 Lithuania: 12.8% 12. 🇸🇰 Slovakia: 12.8% 13. 🇵🇹 Portugal: 12.5% 14. 🇭🇷 Croatia: 12.3% 15. 🇬🇷 Greece: 12.3% 16. 🇫🇷 France: 12.0% 17. 🇭🇺 Hungary: 11.3% 18. 🇱🇻 Latvia: 10.0% 19. 🇦🇹 Austria: 9.8% 20. 🇩🇪 Germany: 9.1% 21. 🇨🇭 Switzerland: 9.1% 22. 🇨🇿 Czechia: 8.8% 23. 🇰🇷 South Korea: 8.5% 24. 🇸🇪 Sweden: 8.4% 25. 🇳🇱 Netherlands: 8.4% 26. 🇪🇪 Estonia: 8.2% 27. 🇧🇪 Belgium: 7.9% 28. 🇵🇱 Poland: 7.8% 29. 🇳🇴 Norway: 6.9% 30. 🇮🇪 Ireland: 6.8% 31. 🇸🇮 Slovenia: 6.2% 32. 🇫🇮 Finland: 4.6% Source: OECD Income Distribution Database. 2023 data, the latest available as of August 2026

Average number of sexual partners: 🇹🇷 Turkey: 14.5 🇦🇺 Australia: 13.3 🇳🇿 New Zealand: 13.2 🇮🇸 Iceland: 13 🇿🇦 South Africa: 12.5 🇫🇮 Finland: 12.4 🇳🇴 Norway: 12.1 🇮🇹 Italy: 11.8 🇸🇪 Sweden: 11.8 🇨🇭 Switzerland: 11.1 🇮🇪 Ireland: 11.1 🇺🇸 USA: 10.7 🇨🇦 Canada: 10.7 🇬🇷 Greece: 10.6 🇯🇵 Japan: 10.2 🇬🇧 UK: 9.8 🇦🇹 Austria: 9.7 🇩🇰 Denmark: 9.3 🇧🇬 Bulgaria: 9.1 🇨🇿 Czechia: 9 🇧🇷 Brazil: 9 🇷🇺 Russia: 9 🇲🇽 Mexico: 9 🇫🇷 France: 8.1 🇭🇷 Croatia: 7.5 🇳🇱 Netherlands: 7 🇵🇹 Portugal: 7 🇭🇺 Hungary: 6.6 🇪🇸 Spain: 6.1 🇵🇱 Poland: 6 🇲🇾 Malaysia: 5.8 🇩🇪 Germany: 5.8 🇸🇰 Slovakia: 5.4 🇨🇳 China: 3.1 🇮🇳 India: 3 Source: World Population Review

Average number of sexual partners: 🇹🇷 Turkey: 14.5 🇦🇺 Australia: 13.3 🇳🇿 New Zealand: 13.2 🇮🇸 Iceland: 13 🇿🇦 South Africa: 12.5 🇫🇮 Finland: 12.4 🇳🇴 Norway: 12.1 🇮🇹 Italy: 11.8 🇸🇪 Sweden: 11.8 🇨🇭 Switzerland: 11.1 🇮🇪 Ireland: 11.1 🇺🇸 USA: 10.7 🇨🇦 Canada: 10.7 🇬🇷 Greece: 10.6 🇯🇵 Japan: 10.2 🇬🇧 UK: 9.8 🇦🇹 Austria: 9.7 🇩🇰 Denmark: 9.3 🇧🇬 Bulgaria: 9.1 🇨🇿 Czechia: 9 🇧🇷 Brazil: 9 🇷🇺 Russia: 9 🇲🇽 Mexico: 9 🇫🇷 France: 8.1 🇭🇷 Croatia: 7.5 🇳🇱 Netherlands: 7 🇵🇹 Portugal: 7 🇭🇺 Hungary: 6.6 🇪🇸 Spain: 6.1 🇵🇱 Poland: 6 🇲🇾 Malaysia: 5.8 🇩🇪 Germany: 5.8 🇸🇰 Slovakia: 5.4 🇨🇳 China: 3.1 🇮🇳 India: 3 Sources: 1. Key Statistics from the National Survey of Family Growth - CDC 2. Male Milestones: Men in Numbers - Manual 3. What’s the Average Person’s Number of Sexual Partners? - Healthline 4. Average number of sexual partners: By Age, Gender, and Country – Promiscuity Statistics - BedBible

$VKTX vs $LLY in terms of Safety and tolerability so far based on available data. Conclusion- $VKTX 17.5 mg Is the best Commercial Dose (de-risked PH3) with best tolerability-to-efficacy ratio and is competitive with retatrutide in efficacy and best in class in safety vs retatrutide. Data here ⬇️⬇️ Retatrutide- Safety TRIUMPH‑1 shows: Nausea: 4 mg: 28.6% 9 mg: 38.4% 12 mg: 42.4% Diarrhea: 4 mg: 25.2% 9 mg: 34.1% 12 mg: 32.0% Placebo: 13.5% Constipation: 4 mg: 23.8% 9 mg: 25.9% 12 mg: 26.1% Placebo: 10.9% Vomiting: 4 mg: 10.6% 9 mg: 22.8% 12 mg: 25.3% Placebo: 4.8% Dysesthesia: 4 mg: 5.1% 9 mg: 12.3% 12 mg: 12.5% Placebo: 0.9% Keep in mind- Skin sensitivity event is not a class-wide GLP/GIP feature, could likely be linked to this molecule. Discontinuation due to AEs 4 mg: 4.1% 9 mg: 6.9% 12 mg: 11.3% Placebo: 4.9% Basically, a double-digit discontinuation at 12mg dose a real risk for commercial take. $VKTX Based on Maintenance data reported last week. My focus is primarily on $17.5mg dose Nausea Placebo: ~10–12% 10 mg: ~15–18% 15 mg: ~18–22% 17.5 mg: ~20–25% 20 mg: ~22–28% 22.5 mg: ~25–30% Vomiting Placebo: ~2–3% 10 mg: ~4–6% 15 mg: ~5–7% 17.5 mg: ~6–8%20 mg: ~7–10% 22.5 mg: ~8–12% Diarrhea Placebo: ~8–10% 10 mg: ~10–12% 15 mg: ~12–14% 17.5 mg: ~12–15% 20 mg: ~14–17% 22.5 mg: ~15–18% Discontinuation Due to AEs Placebo: ~3–4% 10 mg: ~3–4% 15 mg: ~4–5% 17.5 mg: ~4–6% 20 mg: ~5–7% 22.5 mg: ~6–8% Key point: The 17.5 mg discontinuation rate is essentially placebo‑like safety.